摘要
1979年7月~1992年3月共施行经蝶显微外科切除垂体GH腺瘤212例,其中200例有术前后GH测定对比,大腺瘤132例,微腺瘤68例。1986年后的138例在手术方法上进行了改进。本组总治愈缓解率为72.5%,其中大腺瘤的治疗缓解率从1986年前的31.4%提高到69.1%;微腺瘤从44.4%提高到80.5%。1例手术中出现心脏意外死亡,死亡率为0.5%。GH水平动态观察结果显示,术后2周内GH水平与以后的GH水平基本一致,故认为术后2周GH水平可作为判断手术疗效的主要指标。本文对影响疗效的诸因素及术后常见并发症的防治进行了讨论。
From July 1979 to April 1992 ,212 cases of GH-secreting pituitary adenoma were treated transsphenoidally by microsurgical technique,of whom two hundred cases monitored with their GH levels at preoperative and postoperative periods.The majority of cases totally 132 cases were of macroadenoma,and 68 cases were of microadenoma.138 cases were operated on after April 196.The cure and remission rate averaged to 72.5%, rising from 44.4%(before 1986)to 80.5%for microadenoma and from 31.4%to 69.1%for macroadenoma due to improvement of technique and accumulation of experience. One patient died of angiocardiopathy suddenly during operation. Mortality rate was 0.5%。 The follow-up observation of postoperative GH levels in 52 cases revealed that the GH levels within 2 weeks after operation were the same as in 3~6months. It is thought that the early GH levels may represent the surgical results.The surgical technique is described and factors influencing the surgical results, prevention and treatment of operative complications are discussed in this paper.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
1995年第5期333-337,共5页
Acta Academiae Medicinae Sinicae
关键词
垂体肿瘤
生长激素
显微外科手术
pituitary adenoma
growth hormone
microsurgical operation